Myelodysplastic Syndrome (MDS) Latest Advances
Find the Latest Research About Myelodysplastic Syndrome (MDS)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21288 publications
Pearls & Oy-sters: Beyond the Bone Marrow-VEXAS Syndrome Presenting as Subacute Encephalomyelitis.
Journal: Neurology
Published: October 28, 2026
Advances in the management of myelodysplastic neoplasms
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 28, 2026
Multi-hit STAG2 mutations define a high-risk subset of MDS and reveal convergent evolutionary targeting of cohesin.
Journal: bioRxiv : the preprint server for biology
Published: October 24, 2026
Personalized allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes: Integrating molecular risk, donor selection, and post-transplant strategies.
Journal: Cell transplantation
Published: October 18, 2026
Can we better evaluate responses in higher-risk myelodysplastic syndromes?
Journal: Haematologica
Published: October 14, 2026
Aortic-renal aneurysm in a patient with VEXAS syndrome treated with Tocilizumab.
Journal: ARP rheumatology
Published: October 11, 2026
Gecacitinib as a bridging treatment to allogeneic hematopoietic stem cell transplantation for high-risk myelodysplastic syndrome with Behçet's syndrome: a case report
Journal: Zhonghua nei ke za zhi
Published: October 10, 2026
Mutation characteristics and prognosis of SF3B1-mutated myeloid neoplasms: an analysis of 183 patients
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 09, 2026
Clinical Characteristics, Co-Mutations, and Prognostic Factors of TP53 Mutations in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Journal: Clinical laboratory
Published: October 08, 2026
Comparison of Fludarabine/Treosulfan Conditioning with Melphalan-Based Sequential Conditioning in Patients with MDS and Increased Blasts Undergoing Upfront Transplantation.
Journal: Cancers
Published: October 02, 2026
Inflammasome activation promotes the progression of myelodysplastic syndrome.
Journal: Experimental hematology
Published: October 02, 2026
Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Last Updated: 11/08/2026